Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis
about
Melanoma Peptide Vaccines.Involvement of integrin alpha V gene expression in human melanoma tumorigenicityInduction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.Killing of human melanoma cells by the membrane attack complex of human complement as a function of its molecular composition.Role of gangliosides in active immunotherapy with melanoma vaccine.Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy.Evolving role of tumor antigens for future melanoma therapies.Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors.Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes.
P2860
Q30305778-CD7D3A14-1E0A-40EF-97A3-E90BD9B2B9CCQ34222036-874ECC39-CC87-4AAA-98D2-BEFA4DA65741Q34225498-900A5C7B-B8E4-491E-B838-6707D7D79313Q34504625-12A05578-03A8-4807-8110-2EF158D3F177Q35576037-AFFED467-3AFA-4A69-942C-8448A09FE21BQ36930077-8FE38285-D6B0-4572-AD37-9AD7CF7E862DQ37403988-B6C76161-F02C-4BCE-A939-796E7B3867E8Q37974938-1ECBE0BD-BD84-4316-9F6F-674004A98247Q38232855-3C1D6CA1-443E-4631-B7BE-C301971164E1Q40016148-227FEC22-2759-4B9F-A652-0396954BA758Q40813188-BEC2FFA9-5EA4-42A1-B77E-2792EAF24ACEQ40825982-AD6343C9-8BC5-4E02-9AA5-5AB2FFC25891Q49139815-CE48E6C8-B17D-4516-8BB1-7AA82808DA36
P2860
Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disialoganglioside GD3 on huma ...... ibody-mediated tumor cytolysis
@en
Disialoganglioside GD3 on huma ...... body-mediated tumor cytolysis.
@nl
type
label
Disialoganglioside GD3 on huma ...... ibody-mediated tumor cytolysis
@en
Disialoganglioside GD3 on huma ...... body-mediated tumor cytolysis.
@nl
prefLabel
Disialoganglioside GD3 on huma ...... ibody-mediated tumor cytolysis
@en
Disialoganglioside GD3 on huma ...... body-mediated tumor cytolysis.
@nl
P2093
P2860
P356
P1476
Disialoganglioside GD3 on huma ...... ibody-mediated tumor cytolysis
@en
P2093
C J Honsik
D A Cheresh
L K Staffileno
R A Reisfeld
P2860
P304
P356
10.1073/PNAS.82.15.5155
P407
P577
1985-08-01T00:00:00Z